Medical Innovation Exchange

PRI Establishes Working Group to Improve Medical Device Quality and Supply Chain Resiliency



The Performance Review Institute (PRI) has convened a new working group comprised of representatives from the medical device industry, government, and industry associations to identify and recommend best practices to improve medical device quality and enhance supply chain resiliency.

The purpose of the Best Practices in Supply Chain Resiliency and Quality Working Group is to improve medical device quality and supply chain resiliency by expanding MedAccred adoption through the tiers in the supply chain, identifying best practices to supplement efforts in quality assurance and procurement strategies, and to help mitigate supply chain risks.

The working group will provide clear considerations for key stakeholders, including medical device OEMs and contract manufacturers, the U.S. FDA, U.S. Department of Commerce, NIST (National Institute of Standards and Technology) Manufacturing Extension Partnership (NIST MEP), MedAccred, MedMMAP, the Medical Device Innovation Consortium (MDIC), Notified Bodies, Homeland Security, and others.

As part of its efforts, the working group will seek and evaluate lessons learned from other industries including aerospace and automotive. A critical outcome will be to identify the highest value critical manufacturing processes in medical device development with the aim of implementing the MedAccred program to mitigate supply chain risk, reduce quality escapes and improve patient safety.

“This new working group brings together MedAccred, the FDA, U.S. Department of Commerce, and the medical device industry to improve quality, reduce supply chain risks and make best use of technology,” said Bob Lizewski, Vice President of MedAccred and Chairman of the FDA Working Group. “By working together, we aim to review and adapt best practices from across the medical device industry, and develop practical recommendations towards improving patient safety while also reducing the cost to business.”

The new working group was inspired by the U.S. FDA Center for Devices and Radiological Health’s (CDRH) Case for Quality Initiative, which seeks to collaboratively advance the quality, safety, and effectiveness of medical devices to improve patient safety and clinical outcomes. It is being chaired by the MedAccred program, which is administered by the Performance Review Institute.

Working Group members include:

  • Bob Lizewski, VP, MedAccred, Performance Review Institute (Chair)
  • Jay Solomond, EVP and COO, Performance Review Institute
  • Justin McCabe, Operations Manager, MedAccred, Performance Review Institute
  • Kim Killackey, VP, Quality Management System, Baxter Healthcare
  • Srinivas Koneru, Sr. Director, Global Procurement, Baxter Healthcare
  • Tiffany Abrams, Sr. Director, International Quality, Global Sourcing, Edwards Lifesciences
  • Tony Knight, Sr. Director, Global Supplier Quality, Medtronic
  • Scott Goolsbey, Sr. Program Manager – Procurement Programs, Stryker
  • Alberto Romeu Toro, Manager, Global Supplier Quality, Stryker
  • Jeff Bovee, Global Manager, Quality Systems and Regulatory Compliance, Benchmark
  • Ed Engelhard, VP, Corporate Quality, Solar Atmospheres
  • Erin Keith, Sr. Advisor, Compliance and Quality Program, OPEQ, CDRH, FDA
  • Francisco Vicenty, Case for Quality Program Manager, FDA
  • Tammy Beckham, Associate Director, Resilient Supply Chain & Shortages Program, CDRH, OST, FDA
  • Anne P Reid, Deputy Director, Office of Medical Device and Radiological Health Operations, ORA, FDA
  • Rhonda L Mecl, Operations Staff Director, Medical Device and Radiological Health Operations, ORA, FDA
  • Jyoti Malhotra, Divisions Chief of Extension Services at NIST MEP
  • Doug Devereaux, Sr. Industrial Specialist, NIST MEP
  • Andrew Peterson, General Engineer, NIST MEP
  • Bill Donohue, President and Executive Director, Genedge
  • Scott Schein, Director, National Network Programs, Genedge
  • Joe Sapiente, Vice President, Clinical Science & Technology, MDIC
  • Paul Sumner, MDIC Program Director, Case for Quality, MDIC



Related Articles

  • With the increased complexity of devices, a streamlined approach to managing product development risks and documenting compliance is challenging but perhaps more important than ever.

  • UL LLC

    How do the latest requirements affect your business?

  • UL Discusses Cybersecurity Considerations for Medical Devices

    Learn about the current guidance for Cybersecurity in the medical industry and strategies for how you can demonstrate to regulators, purchasers, and users that you’ve addressed these threats.

  • Medical device recall

    The number of recalls also increased 21.5% this quarter, according to Stericycle’s Q3 2019 Recall Index.


Original post:

Post publish date:


Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!